메뉴 건너뛰기




Volumn 60, Issue 1, 2014, Pages 60-67

Ductal carcinoma in situ of the breast: Can biomarkers improve current management?

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN P16; PROTEIN P53; TAMOXIFEN; TUMOR MARKER;

EID: 84891771750     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.207183     Document Type: Review
Times cited : (27)

References (71)
  • 1
    • 0025125259 scopus 로고
    • Evaluation of the increase in breast cancer incidence in relation to mammography use
    • White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82: 1546-52. (Pubitemid 20296504)
    • (1990) Journal of the National Cancer Institute , vol.82 , Issue.19 , pp. 1546-1552
    • White, E.1    Lee, C.Y.2    Kristal, A.R.3
  • 2
    • 84885187137 scopus 로고    scopus 로고
    • Nation-wide data on screening performance during the transition to digital mammography: Observations in 6 million screens
    • National Evaluation Team for Breast Cancer Screening in the Netherlands Study Group (NETB)
    • van Luijt PA, Fracheboud J, Heijnsdijk EA, den Heeten GJ, de Koning HJ; National Evaluation Team for Breast Cancer Screening in the Netherlands Study Group (NETB). Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens. Eur J Cancer 2013;49: 3517-25.
    • (2013) Eur J Cancer , vol.49 , pp. 3517-3525
    • Van Luijt, P.A.1    Fracheboud, J.2    Heijnsdijk, E.A.3    Den Heeten, G.J.4    De Koning, H.J.5
  • 5
    • 79952200754 scopus 로고    scopus 로고
    • Epidemiology of ductal carcinoma in situ
    • Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010: 139-41.
    • (2010) J Natl Cancer Inst Monogr , vol.2010 , pp. 139-141
    • Kerlikowske, K.1
  • 6
    • 0034630285 scopus 로고    scopus 로고
    • Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program
    • Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 2000;160: 953-8. (Pubitemid 30191923)
    • (2000) Archives of Internal Medicine , vol.160 , Issue.7 , pp. 953-958
    • Ernster, V.L.1    Barclay, J.2    Kerlikowske, K.3    Wilkie, H.4    Ballard-Barbash, R.5
  • 9
    • 0029121769 scopus 로고
    • Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy
    • Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA. Continued local recurrence of carcinoma 15-25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76: 1197-200.
    • (1995) Cancer , vol.76 , pp. 1197-1200
    • Page, D.L.1    Dupont, W.D.2    Rogers, L.W.3    Jensen, R.A.4    Schuyler, P.A.5
  • 13
    • 0033178304 scopus 로고    scopus 로고
    • Pathologic findings from the national surgical adjuvant breast project (NSABP) eight-year update of protocol b-17: Intraductal carcinoma
    • DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2- Y
    • Fisher ER, Dignam J, Tan-Chiu E, Costantino J, Fisher B, Paik S, Wolmark N. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma. Cancer 1999;86: 429-38. (Pubitemid 29347405)
    • (1999) Cancer , vol.86 , Issue.3 , pp. 429-438
    • Fisher, E.R.1    Dignam, J.2    Tan-Chiu, E.3    Costantino, J.4    Fisher, B.5    Paik, S.6    Wolmark, N.7
  • 14
    • 0030729519 scopus 로고    scopus 로고
    • Ductal carcinoma in situ of the breast: Correlation of pathologic and mammographic features with extent of disease
    • Coombs JH, Hubbard E, Hudson K, Wunderlich C, VanMeter S, Bell JL, Gwin JL. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease. Am Surg 1997;63: 1079-83. (Pubitemid 27512427)
    • (1997) American Surgeon , vol.63 , Issue.12 , pp. 1079-1083
    • Coombs, J.H.1    Hubbard, E.2    Hudson, K.3    Wunderlich, C.4    Vanmeter, S.5    Bell, J.L.6    Gwin, J.L.7
  • 16
    • 84885907754 scopus 로고    scopus 로고
    • Ductal carcinoma in situ: What the pathologist needs to know and why
    • Bane A. Ductal carcinoma in situ: what the pathologist needs to know and why. Int J Breast Cancer 2013:914053, 2013.
    • (2013) Int J Breast Cancer , vol.2013 , pp. 914053
    • Bane, A.1
  • 18
    • 0028921807 scopus 로고
    • Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators
    • Fisher ER, Costantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer 1995;75: 1310-9.
    • (1995) Cancer , vol.75 , pp. 1310-1319
    • Fisher, E.R.1    Costantino, J.2    Fisher, B.3    Palekar, A.S.4    Redmond, C.5    Mamounas, E.6
  • 19
    • 0035667297 scopus 로고    scopus 로고
    • Clinical practice guidelines for the care and treatment of breast cancer: The management of ductal carcinoma in situ (summary of the 2001 update)
    • Olivotto I, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update). CMAJ 2001;165: 912-3. (Pubitemid 34028232)
    • (2001) Canadian Medical Association Journal , vol.165 , Issue.7 , pp. 912-913
    • Olivotto, I.1    Levine, M.2
  • 20
    • 0032501786 scopus 로고    scopus 로고
    • The steering committee on clinical practice guidelines for the care and treatment of breast cancer. Canadian association of radiation oncologists
    • The management of ductal carcinoma in situ (DCIS).
    • The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ 1998;158 Suppl 3:S27-34.
    • (1998) CMAJ , vol.158 , Issue.SUPPL. 3
  • 22
    • 0142182087 scopus 로고    scopus 로고
    • The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast
    • DOI 10.1016/S0002-9610(03)00265-4, PII S0002961003002654
    • Silverstein MJ. The University of Southern California/ Van Nuys prognostic index for ductal carcinoma in situ of the breast. Am J Surg 2003;186: 337-43. (Pubitemid 38368606)
    • (2003) American Journal of Surgery , vol.186 , Issue.4 , pp. 337-343
    • Silverstein, M.J.1
  • 25
    • 0029965510 scopus 로고    scopus 로고
    • Duct carcinoma in situ: Biological implications for clinical practice
    • Lagios MD. Duct carcinoma in situ: biological implications for clinical practice. Semin Oncol 1996;23: 6-11. (Pubitemid 26105765)
    • (1996) Seminars in Oncology , vol.23 , Issue.1 SUPPL. 2 , pp. 6-11
    • Lagios, M.D.1
  • 26
    • 0037126341 scopus 로고    scopus 로고
    • Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer
    • DOI 10.1056/NEJMoa022152
    • Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002;347: 1233-41. (Pubitemid 35176242)
    • (2002) New England Journal of Medicine , vol.347 , Issue.16 , pp. 1233-1241
    • Fisher, B.1    Anderson, S.2    Bryant, J.3    Margolese, R.G.4    Deutsch, M.5    Fisher, E.R.6    Jeong, J.-H.7    Wolmark, N.8
  • 27
    • 0025177024 scopus 로고
    • Extent, distribution, and mammographic/histological correlations of breast ductal carcinoma in situ
    • DOI 10.1016/0140-6736(90)90747-S
    • Holland R, Hendriks JH, Vebeek AL, Mravunac M, Schuurmans SJ. Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situ. Lancet 1990;335: 519-22. (Pubitemid 20073065)
    • (1990) Lancet , vol.335 , Issue.8688 , pp. 519-522
    • Holland, R.1    Hendriks, J.H.C.L.2    Verbeek, A.L.M.3    Mravunac, M.4    Schuurmans Stekhoven, J.H.5
  • 29
    • 34548319130 scopus 로고    scopus 로고
    • Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: A meta-analysis of randomized trials
    • Viani GA, Stefano EJ, Afonso SL, De Fendi LI, Soares FV, Leon PG, Guimaraes FS. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Radiat Oncol 2007;2:28.
    • (2007) Radiat Oncol , vol.2 , pp. 28
    • Viani, G.A.1    Stefano, E.J.2    Afonso, S.L.3    De Fendi, L.I.4    Soares, F.V.5    Leon, P.G.6    Guimaraes, F.S.7
  • 31
    • 78650717087 scopus 로고    scopus 로고
    • Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
    • Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, et al. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010: 162-77.
    • (2010) J Natl Cancer Inst Monogr , vol.2010 , pp. 162-177
    • Correa, C.1    McGale, P.2    Taylor, C.3    Wang, Y.4    Clarke, M.5    Davies, C.6
  • 33
    • 78650700810 scopus 로고    scopus 로고
    • Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: Long-term results from the UK/ANZ DCIS trial
    • Cuzick J, Sestak I, Pinder SE, Ellis IO, Forsyth S, Bundred NJ, et al. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial. Lancet Oncol 2011;12: 21-9.
    • (2011) Lancet Oncol , vol.12 , pp. 21-29
    • Cuzick, J.1    Sestak, I.2    Pinder, S.E.3    Ellis, I.O.4    Forsyth, S.5    Bundred, N.J.6
  • 34
    • 79952845819 scopus 로고    scopus 로고
    • Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS
    • Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103: 478-88.
    • (2011) J Natl Cancer Inst , vol.103 , pp. 478-488
    • Wapnir, I.L.1    Dignam, J.J.2    Fisher, B.3    Mamounas, E.P.4    Anderson, S.J.5    Julian, T.B.6
  • 37
    • 33644889095 scopus 로고    scopus 로고
    • Ductal carcinoma in situ: Trends in geographic, temporal, and demographic patterns of care and survival
    • DOI 10.1111/j.1075-122X.2006.00182.x
    • Joslyn SA. Ductal carcinoma in situ: trends in geographic, temporal, and demographic patterns of care and survival. Breast J 2006;12: 20-7. (Pubitemid 43381446)
    • (2006) Breast Journal , vol.12 , Issue.1 , pp. 20-27
    • Joslyn, S.A.1
  • 39
    • 73949085809 scopus 로고    scopus 로고
    • Local excision alone without irradiation for ductal carcinoma in situ of the breast: A trial of the Eastern Cooperative Oncology Group
    • Hughes LL, Wang M, Page DL, Gray R, Solin LJ, Davidson NE, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27: 5319-24.
    • (2009) J Clin Oncol , vol.27 , pp. 5319-5324
    • Hughes, L.L.1    Wang, M.2    Page, D.L.3    Gray, R.4    Solin, L.J.5    Davidson, N.E.6
  • 41
    • 84891529657 scopus 로고    scopus 로고
    • Low-risk breast ductal carcinoma in situ (DCIS): Results from the Radiation Therapy Oncology Group 9804 phase 3 trial
    • McCormick B, Moughan J, Hudis C, Kuerer H, Rakovitch E, Smith B, et al. Low-risk breast ductal carcinoma in situ (DCIS): results from the Radiation Therapy Oncology Group 9804 phase 3 trial. Int J Radiat Oncol Biol Phys 2012;84:S5.
    • (2012) Int J Radiat Oncol Biol Phys , vol.84
    • McCormick, B.1    Moughan, J.2    Hudis, C.3    Kuerer, H.4    Rakovitch, E.5    Smith, B.6
  • 43
    • 38049069125 scopus 로고    scopus 로고
    • Patterns of care analysis among women with ductal carcinoma in situ in North Carolina
    • Jackson LC, Camacho F, Levine EA, Anderson RT, Stewart JH. Patterns of care analysis among women with ductal carcinoma in situ in North Carolina. Am J Surg 2008;195: 164-9.
    • (2008) Am J Surg , vol.195 , pp. 164-169
    • Jackson, L.C.1    Camacho, F.2    Levine, E.A.3    Anderson, R.T.4    Stewart, J.H.5
  • 44
    • 78651372009 scopus 로고    scopus 로고
    • Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone
    • Wai ES, Lesperance ML, Alexander CS, Truong PT, Moccia P, Culp M, et al. Predictors of local recurrence in a population-based cohort of women with ductal carcinoma in situ treated with breast conserving surgery alone. Ann Surg Oncol 2011; 18: 119-24.
    • (2011) Ann Surg Oncol , vol.18 , pp. 119-124
    • Wai, E.S.1    Lesperance, M.L.2    Alexander, C.S.3    Truong, P.T.4    Moccia, P.5    Culp, M.6
  • 45
    • 33746811910 scopus 로고    scopus 로고
    • Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: Ten-year results of european organisation for research and treatment of cancer randomized phase III trial 10853 - A study by the EORTC breast cancer cooperative group and EORTC radiotherapy group
    • DOI 10.1200/JCO.2006.06.1366
    • Bijker N, Meijnen P, Peterse JL, Bogaerts J, Van H, I, Julien JP, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinomain- situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853-a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. J Clin Oncol 2006;24: 3381-7. (Pubitemid 46638893)
    • (2006) Journal of Clinical Oncology , vol.24 , Issue.21 , pp. 3381-3387
    • Bijker, N.1    Meijnen, P.2    Peterse, J.L.3    Bogaerts, J.4    Van Hoorebeeck, I.5    Julien, J.-P.6    Gennaro, M.7    Rouanet, P.8    Avril, A.9    Fentiman, I.S.10    Bartelink, H.11    Rutgers, E.J.Th.12
  • 46
    • 84879413438 scopus 로고    scopus 로고
    • Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis
    • Rakovitch E, Nofech-Mozes S, Narod SA, Hanna W, Thiruchelvam D, Saskin R, et al. Can we select individuals with low risk ductal carcinoma in situ (DCIS)? A population-based outcomes analysis. Breast Cancer Res Treat 2013;138: 581-90.
    • (2013) Breast Cancer Res Treat , vol.138 , pp. 581-590
    • Rakovitch, E.1    Nofech-Mozes, S.2    Narod, S.A.3    Hanna, W.4    Thiruchelvam, D.5    Saskin, R.6
  • 48
    • 70350710119 scopus 로고    scopus 로고
    • Rethinking screening for breast cancer and prostate cancer
    • Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA 2009;302: 1685-92.
    • (2009) JAMA , vol.302 , pp. 1685-1692
    • Esserman, L.1    Shieh, Y.2    Thompson, I.3
  • 49
    • 79952284127 scopus 로고    scopus 로고
    • Hallmarks of cancer: The next generation
    • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144: 646-74.
    • (2011) Cell , vol.144 , pp. 646-674
    • Hanahan, D.1    Weinberg, R.A.2
  • 50
    • 0008376153 scopus 로고
    • Smoking and carcinoma of the lung; Preliminary report
    • Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950;2: 739-48.
    • (1950) Br Med J , vol.2 , pp. 739-748
    • Doll, R.1    Hill, A.B.2
  • 51
    • 34248678430 scopus 로고    scopus 로고
    • Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis
    • DOI 10.1016/j.molonc.2007.01.004, PII S1574789107000105
    • Herceg Z, Hainaut P. Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Mol Oncol 2007;1: 26-41. (Pubitemid 46776619)
    • (2007) Molecular Oncology , vol.1 , Issue.1 , pp. 26-41
    • Herceg, Z.1    Hainaut, P.2
  • 52
    • 84867232961 scopus 로고    scopus 로고
    • Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast
    • Liao S, Desouki MM, Gaile DP, Shepherd L, Nowak NJ, Conroy J, et al. Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast. Genes Chromosomes Cancer 2012;51: 1067-78.
    • (2012) Genes Chromosomes Cancer , vol.51 , pp. 1067-1078
    • Liao, S.1    Desouki, M.M.2    Gaile, D.P.3    Shepherd, L.4    Nowak, N.J.5    Conroy, J.6
  • 53
    • 51649118175 scopus 로고    scopus 로고
    • Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: A calibrated aCGH study
    • Iakovlev VV, Arneson NCR, Wong V, Wang C, Leung S, Iakovleva G, et al. Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease: a calibrated aCGH study. Clin Cancer Res 2008; 14: 4446-54.
    • (2008) Clin Cancer Res , vol.14 , pp. 4446-4454
    • Iakovlev, V.V.1    Arneson, N.C.R.2    Wong, V.3    Wang, C.4    Leung, S.5    Iakovleva, G.6
  • 54
    • 33646253192 scopus 로고    scopus 로고
    • Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression
    • Yao J, Weremowicz S, Feng B, Gentleman RC, Marks JR, Gelman R, et al. Combined cDNA array comparative genomic hybridization and serial analysis of gene expression analysis of breast tumor progression. Cancer Res 2006;66: 4065-78.
    • (2006) Cancer Res , vol.66 , pp. 4065-4078
    • Yao, J.1    Weremowicz, S.2    Feng, B.3    Gentleman, R.C.4    Marks, J.R.5    Gelman, R.6
  • 55
    • 43049117148 scopus 로고    scopus 로고
    • The molecular journey from ductal carcinoma in situ to invasive breast cancer
    • DOI 10.1002/cncr.23430
    • Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008;112: 2130-42. (Pubitemid 351628621)
    • (2008) Cancer , vol.112 , Issue.10 , pp. 2130-2142
    • Wiechmann, L.1    Kuerer, H.M.2
  • 57
    • 84858285120 scopus 로고    scopus 로고
    • HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
    • Rakovitch E, Nofech-Mozes S, Hanna W, Narod S, Thiruchelvam D, Saskin R, et al. HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2012;106: 1160-5.
    • (2012) Br J Cancer , vol.106 , pp. 1160-1165
    • Rakovitch, E.1    Nofech-Mozes, S.2    Hanna, W.3    Narod, S.4    Thiruchelvam, D.5    Saskin, R.6
  • 58
    • 80053646326 scopus 로고    scopus 로고
    • Biological markers in DCIS and risk of breast recurrence: A systematic review
    • Lari SA, Kuerer HM. Biological markers in DCIS and risk of breast recurrence: a systematic review. J Cancer 2011;2: 232-61.
    • (2011) J Cancer , vol.2 , pp. 232-261
    • Lari, S.A.1    Kuerer, H.M.2
  • 62
    • 78650028237 scopus 로고    scopus 로고
    • The molecular pathology of breast cancer progression
    • Bombonati A, Sgroi DC. The molecular pathology of breast cancer progression. J Pathol 2011;223: 307-17.
    • (2011) J Pathol , vol.223 , pp. 307-317
    • Bombonati, A.1    Sgroi, D.C.2
  • 63
    • 34447635558 scopus 로고    scopus 로고
    • Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast
    • Steinman S, Wang J, Bourne P, Yang Q, Tang P. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Ann Clin Lab Sci 2007;37: 127-34. (Pubitemid 46717189)
    • (2007) Annals of Clinical and Laboratory Science , vol.37 , Issue.2 , pp. 127-134
    • Steinman, S.1    Wang, J.2    Bourne, P.3    Yang, Q.4    Tang, P.5
  • 64
    • 84857517254 scopus 로고    scopus 로고
    • Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: The search continues
    • Solin LJ. Selecting individualized treatment for patients with ductal carcinoma in situ of the breast: the search continues. J Clin Oncol 2012; 30: 577-9.
    • (2012) J Clin Oncol , vol.30 , pp. 577-579
    • Solin, L.J.1
  • 65
    • 0242380840 scopus 로고    scopus 로고
    • Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast
    • DOI 10.1016/S0959-8049(02)00666-4, PII S0959804902006664
    • Provenzano E, Hopper JL, Giles GG, Marr G, Venter DJ, Armes JE. Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast. Eur J Cancer 2003;39: 622-30. (Pubitemid 36287374)
    • (2003) European Journal of Cancer , vol.39 , Issue.5 , pp. 622-630
    • Provenzano, E.1    Hopper, J.L.2    Giles, G.G.3    Marr, G.4    Venter, D.J.5    Armes, J.E.6
  • 67
    • 80051513712 scopus 로고    scopus 로고
    • Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone
    • Holmes P, Lloyd J, Chervoneva I, Pequinot E, Cornfield DB, Schwartz GF, et al. Prognostic markers and long-term outcomes in ductal carcinoma in situ of the breast treated with excision alone. Cancer 2011;117: 3650-7.
    • (2011) Cancer , vol.117 , pp. 3650-3657
    • Holmes, P.1    Lloyd, J.2    Chervoneva, I.3    Pequinot, E.4    Cornfield, D.B.5    Schwartz, G.F.6
  • 68
    • 0034892084 scopus 로고    scopus 로고
    • Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics
    • DOI 10.1016/S0959-8049(01)00165-4, PII S0959804901001654
    • Ringberg A, Anagnostaki L, Anderson H, Idvall I, Ferno M. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. European Journal of Cancer 2001; 37: 1514-22. (Pubitemid 32744682)
    • (2001) European Journal of Cancer , vol.37 , Issue.12 , pp. 1514-1522
    • Ringberg, A.1    Anagnostaki, L.2    Anderson, H.3    Idvall, I.4    Ferno, M.5
  • 69
    • 81155133281 scopus 로고    scopus 로고
    • Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer
    • Cuzick J, Dowsett M, Pineda S, Wale C, Salter J, Quinn E, et al. Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the genomic health recurrence score in early breast cancer. J Clin Oncol 2011;29: 4273-8.
    • (2011) J Clin Oncol , vol.29 , pp. 4273-4278
    • Cuzick, J.1    Dowsett, M.2    Pineda, S.3    Wale, C.4    Salter, J.5    Quinn, E.6
  • 70
    • 84891784645 scopus 로고    scopus 로고
    • The TEAM trial pathology study identifies potential prognostic and predictive biomarker models for postmenopausal patients treated with endocrine therapy
    • Bartlett JMS, Brookes C, Robson T, van de Velde CH, Billingham LJ, Campbell FM, et al. The TEAM trial pathology study identifies potential prognostic and predictive biomarker models for postmenopausal patients treated with endocrine therapy. Cancer Res 2009;69:503S.
    • (2009) Cancer Res , vol.69
    • Bartlett, J.M.S.1    Brookes, C.2    Robson, T.3    Van De Velde, C.H.4    Billingham, L.J.5    Campbell, F.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.